MeSH term
Frequency | Condition_Probility | Humans | 414 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Rats | 21 | 0.0 |
Rats, Sprague-Dawley | 5 | 0.0 |
Receptors, Complement/metabolism | 2 | 3.0 |
Research Support, Non-U.S. Gov't | 239 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 128 | 0.0 |
Animals | 141 | 0.0 |
Cell Division/physiology | 2 | 0.0 |
Immunohistochemistry | 17 | 0.0 |
*Linoleic Acids, Conjugated | 2 | 50.0 |
Tumor Cells, Cultured | 26 | 0.0 |
Antibodies, Monoclonal/metabolism | 3 | 0.0 |
Complement 9/*immunology | 14 | 87.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Flow Cytometry | 4 | 0.0 |
Transfection | 8 | 0.0 |
Alleles | 3 | 0.0 |
Base Sequence | 24 | 0.0 |
Cloning, Molecular | 11 | 0.0 |
Complement 9/*genetics | 8 | 100.0 |
DNA/genetics | 4 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Exons | 7 | 0.0 |
Introns | 5 | 0.0 |
Molecular Sequence Data | 42 | 0.0 |
Polymerase Chain Reaction | 10 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Child, Preschool | 14 | 0.0 |
Female | 95 | 0.0 |
Male | 87 | 0.0 |
Phenotype | 4 | 0.0 |
Risk Factors | 3 | 0.0 |
Apoptosis/drug effects | 2 | 0.0 |
Cell Division/drug effects | 8 | 0.0 |
Isomerism | 10 | 4.0 |
Diet | 2 | 0.0 |
Milk, Human/*chemistry | 2 | 4.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 31 | 0.0 |
Stereoisomerism | 2 | 0.0 |
Carbon Radioisotopes | 6 | 7.0 |
Cell Survival/drug effects | 5 | 0.0 |
Dinoprost/metabolism | 2 | 18.0 |
Linoleic Acid/*pharmacology | 3 | 42.0 |
Binding, Competitive | 5 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Substrate Specificity | 3 | 0.0 |
*Complement Activation | 28 | 7.0 |
Complement Membrane Attack Complex/metabolism | 9 | 26.0 |
Adult | 83 | 0.0 |
Complement/*deficiency | 5 | 10.0 |
Complement Hemolytic Activity Assay | 4 | 8.0 |
English Abstract | 26 | 0.0 |
Japan/epidemiology | 3 | 0.0 |
Mass Screening | 2 | 1.0 |
Middle Aged | 64 | 0.0 |
Prevalence | 3 | 0.0 |
Cell Line | 17 | 0.0 |
Comparative Study | 39 | 0.0 |
Tritium | 2 | 0.0 |
Diagnosis, Differential | 5 | 0.0 |
Recurrence | 7 | 0.0 |
Cells, Cultured | 17 | 0.0 |
Complement Membrane Attack Complex/analysis | 2 | 12.0 |
Perfusion | 2 | 0.0 |
Swine | 5 | 0.0 |
Mice | 40 | 0.0 |
Oxidation-Reduction | 5 | 0.0 |
Time Factors | 15 | 0.0 |
Aged | 40 | 0.0 |
Aged, 80 and over | 14 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Lipids/*blood | 2 | 0.0 |
Autopsy | 3 | 1.0 |
Biological Markers | 2 | 0.0 |
Complement 9/*analysis | 13 | 100.0 |
Myocardial Infarction/*diagnosis | 2 | 20.0 |
Sensitivity and Specificity | 3 | 0.0 |
Proteasome Endopeptidase Complex | 4 | 0.0 |
Complement/*metabolism | 32 | 18.0 |
Immunoenzyme Techniques | 7 | 0.0 |
Peroxidase/blood | 2 | 4.0 |
Pregnancy | 8 | 0.0 |
Immunoglobulin A/analysis | 5 | 3.0 |
*Adaptor Proteins, Vesicular Transport | 2 | 0.0 |
DNA, Complementary | 4 | 0.0 |
Cattle | 8 | 0.0 |
Dose-Response Relationship, Drug | 6 | 0.0 |
Administration, Oral | 2 | 0.0 |
Double-Blind Method | 2 | 0.0 |
Amino Acid Sequence | 38 | 0.0 |
Antigens, CD/analysis | 2 | 0.0 |
Cytotoxicity, Immunologic | 5 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 28 | 0.0 |
Fluorescent Antibody Technique | 22 | 0.0 |
Gene Expression | 6 | 0.0 |
Solubility | 7 | 0.0 |
Complement 9/deficiency/*genetics | 3 | 100.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Mutation | 4 | 0.0 |
Complement Factor B/physiology | 2 | 18.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Cell Count | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Binding Sites, Antibody | 6 | 1.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Rabbits | 27 | 0.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Complement 9/metabolism | 21 | 63.0 |
Complement Membrane Attack Complex/*metabolism | 6 | 28.0 |
Ouabain/pharmacology | 2 | 3.0 |
Rats, Wistar | 2 | 0.0 |
Biological Markers/analysis | 4 | 0.0 |
Indicators and Reagents | 2 | 0.0 |
C-Reactive Protein/analysis | 8 | 1.0 |
Complement/*analysis | 26 | 15.0 |
Complement 3/analysis | 15 | 4.0 |
Complement 4/analysis | 8 | 3.0 |
Complement 9/analysis | 16 | 61.0 |
Complement Activation | 22 | 7.0 |
Complement Factor B/analysis | 2 | 4.0 |
Gestational Age | 3 | 0.0 |
Glycoproteins/*analysis | 3 | 4.0 |
Immunoassay | 2 | 0.0 |
Infant, Newborn | 6 | 0.0 |
Leukocyte Count | 2 | 0.0 |
Longitudinal Studies | 2 | 0.0 |
Cell Membrane/immunology/metabolism | 2 | 1.0 |
Cytotoxicity, Immunologic/immunology | 3 | 4.0 |
Dose-Response Relationship, Immunologic | 5 | 0.0 |
Protein Biosynthesis | 5 | 0.0 |
Hemolysis/drug effects | 5 | 8.0 |
Immunoblotting | 4 | 0.0 |
Complement 8/*genetics | 3 | 23.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Epitopes | 8 | 0.0 |
Microscopy, Immunoelectron | 6 | 1.0 |
Protein Binding | 17 | 0.0 |
Thrombospondins | 2 | 1.0 |
Chromatography, Gas | 2 | 2.0 |
Chromatography, Thin Layer | 5 | 3.0 |
Milk/chemistry | 2 | 13.0 |
Complement 5/genetics | 2 | 50.0 |
Complement 8/chemistry/*genetics | 2 | 66.0 |
*Evolution, Molecular | 2 | 0.0 |
Homozygote | 4 | 0.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
Electrophoresis, Gel, Two-Dimensional | 2 | 0.0 |
Protein Conformation | 17 | 0.0 |
Species Specificity | 18 | 0.0 |
Chromosomes, Human, Pair 5 | 3 | 2.0 |
Complement 7/*genetics | 4 | 26.0 |
Genetic Markers | 2 | 0.0 |
Haplotypes | 4 | 0.0 |
Binding Sites | 17 | 0.0 |
Complement 9/*metabolism | 32 | 88.0 |
Hemolysis | 41 | 13.0 |
K562 Cells | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Sheep | 18 | 3.0 |
Binding Sites/genetics | 2 | 0.0 |
Complement 8/chemistry/genetics/*metabolism | 2 | 100.0 |
Antibodies, Monoclonal | 9 | 0.0 |
Blotting, Western | 9 | 0.0 |
Complement 3/immunology | 4 | 5.0 |
Complement 9/*immunology/physiology | 2 | 100.0 |
Complement Pathway, Alternative/physiology | 2 | 40.0 |
Enzyme-Linked Immunosorbent Assay | 16 | 0.0 |
Microscopy, Fluorescence | 5 | 0.0 |
Mice, Inbred NOD | 2 | 0.0 |
*Mutation | 3 | 0.0 |
Complement Activation/*physiology | 4 | 16.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Reference Values | 3 | 0.0 |
Animals, Genetically Modified | 3 | 1.0 |
Immunoglobulin M/analysis | 4 | 1.0 |
Acute Disease | 3 | 0.0 |
Chromatography, Gas/methods | 2 | 18.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
Linoleic Acids, Conjugated/chemistry/*metabolism | 2 | 100.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Karyotyping | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Blood Proteins/metabolism | 3 | 1.0 |
Complement 5/metabolism | 10 | 23.0 |
Complement 8/metabolism | 8 | 72.0 |
Cytokines/*blood | 2 | 0.0 |
Interleukin-6/blood | 2 | 0.0 |
Transferrin/metabolism | 3 | 1.0 |
Adolescent | 24 | 0.0 |
Child | 22 | 0.0 |
Japan | 5 | 0.0 |
Cell Division | 2 | 0.0 |
Kinetics | 32 | 0.0 |
Calcium/*metabolism | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Serum Albumin, Bovine/pharmacology | 3 | 9.0 |
Complement 3/*metabolism | 2 | 1.0 |
Enzyme-Linked Immunosorbent Assay/*methods | 4 | 2.0 |
Chickens | 2 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
Fibronectins/metabolism | 2 | 1.0 |
Animals, Newborn | 2 | 0.0 |
Blood Bactericidal Activity | 5 | 5.0 |
In Vitro | 26 | 0.0 |
Staining and Labeling/methods | 3 | 2.0 |
Age Factors | 3 | 0.0 |
Fluorescein-5-isothiocyanate | 3 | 2.0 |
Fluorescent Dyes | 2 | 0.0 |
Glycoproteins/metabolism/*pharmacology | 2 | 25.0 |
*Molecular Chaperones | 3 | 2.0 |
Scattering, Radiation | 4 | 3.0 |
Spectrometry, Fluorescence | 3 | 0.0 |
*Blood Bactericidal Activity | 11 | 23.0 |
Complement/*immunology | 14 | 9.0 |
Complement 8/deficiency | 2 | 50.0 |
Complement Membrane Attack Complex/*immunology | 2 | 20.0 |
Escherichia coli/*immunology | 3 | 8.0 |
Apoptosis/*drug effects | 3 | 0.0 |
Breast Neoplasms/*pathology | 2 | 0.0 |
Linoleic Acids, Conjugated/*pharmacology | 4 | 80.0 |
Complement 8/physiology | 2 | 50.0 |
Complement 9/*deficiency/genetics | 3 | 75.0 |
Complement Pathway, Alternative | 7 | 6.0 |
Heterozygote | 5 | 0.0 |
Complement 6/genetics | 3 | 33.0 |
Complement 7/genetics | 2 | 66.0 |
Genes, Structural | 2 | 0.0 |
Pedigree | 8 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Computer Simulation | 2 | 0.0 |
Erythrocytes/immunology | 7 | 2.0 |
Macromolecular Substances | 27 | 1.0 |
Neutrophils/immunology | 3 | 1.0 |
Polymers | 5 | 4.0 |
Structure-Activity Relationship | 8 | 0.0 |
Prognosis | 4 | 0.0 |
Immunoglobulins/metabolism | 5 | 4.0 |
Receptors, Complement/*metabolism | 2 | 1.0 |
Erythrocyte Membrane/immunology | 3 | 7.0 |
Chromosome Mapping | 3 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
DNA Probes | 3 | 0.0 |
Gene Library | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Restriction Mapping | 4 | 0.0 |
Complement/*physiology | 11 | 12.0 |
Complement 1/metabolism | 2 | 5.0 |
Heat | 6 | 1.0 |
Prospective Studies | 4 | 0.0 |
*Cytotoxicity, Immunologic | 9 | 1.0 |
Autoimmune Diseases/*immunology | 2 | 1.0 |
Complement/metabolism | 14 | 14.0 |
Lupus Erythematosus, Systemic/*immunology | 3 | 2.0 |
Metabolic Clearance Rate | 2 | 0.0 |
Complement Membrane Attack Complex | 53 | 67.0 |
Disulfides | 2 | 2.0 |
Peptide Fragments/metabolism | 2 | 0.0 |
Blood Proteins/*analysis | 3 | 2.0 |
Infant | 7 | 0.0 |
Complement 9/*chemistry | 4 | 80.0 |
Disulfides/*chemistry | 2 | 5.0 |
*Hydroxysteroid Dehydrogenases | 2 | 13.0 |
Liver/*enzymology | 2 | 0.0 |
*Membrane Glycoproteins | 10 | 1.0 |
Basement Membrane/immunology/pathology | 2 | 22.0 |
Complement Membrane Attack Complex/*antagonists & inhibitors | 2 | 14.0 |
Complement/analysis | 7 | 5.0 |
Complement 9/analysis/*deficiency | 4 | 100.0 |
Microscopy, Electron | 15 | 0.0 |
Antigens, CD59 | 11 | 5.0 |
Complement 3b/metabolism | 2 | 1.0 |
Complement 7/metabolism | 5 | 50.0 |
Complement Membrane Attack Complex/physiology | 2 | 28.0 |
Hydrogen-Ion Concentration | 4 | 0.0 |
Immunoglobulin G/pharmacology | 2 | 3.0 |
Antigens, CD/*metabolism | 4 | 0.0 |
Membrane Glycoproteins/*metabolism | 4 | 0.0 |
Complement/*genetics | 3 | 5.0 |
Complement 9/genetics | 2 | 33.0 |
Genomic Library | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Glycoproteins/*metabolism | 2 | 1.0 |
Tissue Distribution | 3 | 0.0 |
Complement 5/immunology | 5 | 29.0 |
Complement Inactivators/*pharmacology | 2 | 7.0 |
Blood Vessels/immunology | 2 | 33.0 |
Kidney Diseases/immunology/*pathology | 2 | 50.0 |
Complement 1/analysis | 4 | 8.0 |
Complement 2/analysis | 2 | 6.0 |
Complement 5/*metabolism | 2 | 8.0 |
Complement Activation/*drug effects | 4 | 4.0 |
Neutrophils/enzymology | 2 | 2.0 |
Cell Survival | 2 | 0.0 |
Complement 3/*biosynthesis | 3 | 6.0 |
Complement 5/*biosynthesis | 2 | 50.0 |
Trout | 3 | 21.0 |
Peptide Fragments/*metabolism | 2 | 1.0 |
Antigens, CD55 | 4 | 2.0 |
*Complement Pathway, Classical | 2 | 2.0 |
Melanoma/immunology | 2 | 5.0 |
Complement 9/*deficiency | 6 | 100.0 |
Complement 8/analysis | 2 | 50.0 |
Complement Inactivators/*physiology | 2 | 10.0 |
Blood Bactericidal Activity/*drug effects | 2 | 28.0 |
Lipopolysaccharides/metabolism | 2 | 1.0 |
Membrane Proteins/*deficiency | 2 | 25.0 |
*Antigens, CD59 | 4 | 50.0 |
Complement 8/*metabolism | 9 | 75.0 |
Erythrocyte Membrane/*metabolism | 5 | 7.0 |
Hemolysis/*drug effects | 3 | 7.0 |
Vitronectin | 6 | 16.0 |
Complement Membrane Attack Complex/*physiology | 3 | 33.0 |
*Hemolysis | 11 | 12.0 |
Complement 1q/analysis/metabolism | 2 | 100.0 |
Sodium Dodecyl Sulfate | 3 | 5.0 |
Complement/analysis/*deficiency | 3 | 42.0 |
Complement Fixation Tests | 3 | 3.0 |
Complement Pathway, Alternative/drug effects | 3 | 14.0 |
Complement Pathway, Classical/drug effects | 3 | 13.0 |
Lipopolysaccharides/pharmacology | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 6 | 0.0 |
Complement 1q/metabolism | 2 | 8.0 |
Complement 3/metabolism | 16 | 6.0 |
Skin Tests | 2 | 1.0 |
Membrane Glycoproteins/analysis | 2 | 0.0 |
Neutrons | 3 | 20.0 |
DNA | 2 | 0.0 |
Macrophages/*metabolism | 3 | 1.0 |
Antibody Specificity | 8 | 0.0 |
Autoantigens/*immunology | 2 | 1.0 |
Capsid/*immunology | 2 | 15.0 |
Cross Reactions | 9 | 1.0 |
Mice, Inbred BALB C | 4 | 0.0 |
Rubella virus/*immunology | 2 | 40.0 |
Mice, Inbred Strains | 2 | 0.0 |
*Complement 5 | 3 | 33.0 |
Guinea Pigs | 16 | 1.0 |
Molecular Weight | 20 | 0.0 |
Osmolar Concentration | 3 | 0.0 |
Immunoglobulin G/analysis | 6 | 1.0 |
Affinity Labels | 2 | 3.0 |
Lipids/*metabolism | 3 | 1.0 |
Receptors, LDL/genetics | 2 | 2.0 |
Complement 6/*genetics | 2 | 14.0 |
Blotting, Northern | 2 | 0.0 |
Properdin/metabolism | 2 | 13.0 |
Chronic Disease | 4 | 0.0 |
CD4-Positive T-Lymphocytes/*immunology | 2 | 0.0 |
Clone Cells/immunology | 2 | 1.0 |
Epitopes/immunology | 4 | 0.0 |
T-Lymphocytes, Cytotoxic/*immunology | 3 | 0.0 |
Complement 9/*isolation & purification | 3 | 75.0 |
Autoradiography | 3 | 0.0 |
Centrifugation, Density Gradient | 8 | 2.0 |
Escherichia coli/immunology | 2 | 2.0 |
Immunoglobulin G/immunology | 3 | 0.0 |
Antibodies, Monoclonal/*immunology | 8 | 1.0 |
Complement 9/immunology/*metabolism | 2 | 100.0 |
Complement Factor B/metabolism | 2 | 4.0 |
Antibodies, Fungal | 2 | 33.0 |
*Antibodies, Monoclonal | 3 | 1.0 |
Antigens, Fungal | 2 | 28.0 |
Aspergillosis/immunology | 2 | 100.0 |
Aspergillus fumigatus/growth & development/*immunology/ultrastructure | 2 | 100.0 |
Cell Wall/immunology | 2 | 10.0 |
Cytoplasm/immunology | 3 | 3.0 |
Spores, Fungal/immunology | 2 | 33.0 |
Complement 5/deficiency | 2 | 20.0 |
Meningitis, Meningococcal/*etiology | 2 | 66.0 |
Chromatography, Gel | 5 | 0.0 |
Precipitation | 4 | 2.0 |
Complement 9/*chemistry/isolation & purification | 2 | 100.0 |
Mathematics | 2 | 1.0 |
Models, Molecular | 2 | 0.0 |
Antibodies/immunology | 3 | 0.0 |
Immunosorbent Techniques | 5 | 1.0 |
Arachidonic Acid/metabolism | 2 | 2.0 |
Arthritis, Rheumatoid/*immunology | 4 | 1.0 |
HLA Antigens/immunology | 2 | 1.0 |
Lymphocyte Activation | 5 | 0.0 |
Calcium/metabolism | 2 | 0.0 |
Ion Channels/*physiology | 3 | 9.0 |
Phospholipids/metabolism | 5 | 2.0 |
Polymers/metabolism | 3 | 6.0 |
Zinc/pharmacology | 5 | 7.0 |
Blood Proteins/*metabolism | 5 | 2.0 |
Edetic Acid/pharmacology | 2 | 1.0 |
alpha 1-Antitrypsin/metabolism | 2 | 4.0 |
alpha-Macroglobulins/metabolism | 2 | 4.0 |
Complement 9/immunology | 11 | 64.0 |
Complement Membrane Attack Complex/*analysis | 2 | 15.0 |
Epitopes/analysis | 4 | 1.0 |
Insulin/*pharmacology | 2 | 0.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
Buffers | 2 | 1.0 |
Protein Denaturation | 2 | 0.0 |
Antigen-Antibody Complex/*analysis | 4 | 2.0 |
Complement Membrane Attack Complex/immunology | 3 | 30.0 |
Glomerulonephritis, IGA/immunology | 2 | 66.0 |
Glomerulonephritis, Membranoproliferative/immunology | 2 | 33.0 |
Glomerulonephritis, Membranous/immunology | 2 | 100.0 |
Lamins | 2 | 3.0 |
Sequence Homology, Nucleic Acid | 5 | 0.0 |
Antibodies, Monoclonal/diagnostic use | 5 | 0.0 |
Complement/analysis/metabolism/*physiology | 2 | 100.0 |
Complement Membrane Attack Complex/*biosynthesis | 2 | 28.0 |
Sepharose/metabolism | 2 | 11.0 |
Complement 9/physiology | 3 | 42.0 |
Electric Conductivity | 3 | 1.0 |
Membrane Proteins/immunology | 3 | 5.0 |
Membrane Proteins/*ultrastructure | 2 | 100.0 |
Peptide Fragments/analysis | 2 | 0.0 |
Phosphatidylcholines | 2 | 5.0 |
Electrophoresis, Polyacrylamide Gel/methods | 2 | 1.0 |
Antigens/*analysis | 2 | 2.0 |
Blood Proteins/analysis | 5 | 3.0 |
Skin/immunology | 2 | 2.0 |
Immunoglobulins/analysis | 6 | 2.0 |
*Carrier Proteins | 3 | 0.0 |
Complement 8/*immunology | 3 | 60.0 |
Immunodiffusion | 8 | 3.0 |
Cysteine | 3 | 2.0 |
Membrane Proteins/*immunology | 2 | 3.0 |
Complement 6/immunology | 2 | 100.0 |
Complement 7/immunology | 4 | 100.0 |
Complement 8/immunology | 5 | 55.0 |
Hemolysis/*immunology | 2 | 15.0 |
Blood Platelets/*physiology | 2 | 1.0 |
Cell Membrane/immunology/physiology | 2 | 22.0 |
Erythrocyte Membrane/*immunology | 6 | 12.0 |
Biopsy | 2 | 0.0 |
Immunologic Techniques | 4 | 1.0 |
Complement 9/analysis/*cerebrospinal fluid | 2 | 100.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Colitis, Ulcerative/*immunology | 2 | 5.0 |
Crohn Disease/*immunology | 2 | 5.0 |
Complement/immunology/*metabolism/physiology | 2 | 100.0 |
Immune Sera | 8 | 2.0 |
Iodine Radioisotopes | 4 | 1.0 |
Precipitin Tests | 2 | 0.0 |
Temperature | 4 | 0.0 |
Pemphigus/*immunology | 2 | 4.0 |
Antigens/analysis | 3 | 2.0 |
Complement/biosynthesis/*metabolism | 2 | 66.0 |
Skin/*immunology | 2 | 1.0 |
Complement 5/analysis | 6 | 13.0 |
Complement 7/analysis | 3 | 27.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
Dicarboxylic Acids/*pharmacology | 2 | 66.0 |
Complement/*biosynthesis | 2 | 5.0 |
*Complement Pathway, Alternative | 8 | 7.0 |
Complement 1q | 6 | 5.0 |
Trypsin/pharmacology | 2 | 1.0 |
Antigen-Antibody Reactions | 3 | 0.0 |
Complement/immunology | 7 | 7.0 |
Complement 4/immunology | 2 | 5.0 |
Complement Pathway, Classical | 9 | 7.0 |
Immunoglobulin M/immunology | 2 | 1.0 |
Glomerulonephritis/*immunology | 3 | 7.0 |
*Cell Membrane Permeability | 2 | 8.0 |
Liposomes | 3 | 1.0 |
Models, Biological | 3 | 0.0 |
Body Temperature | 2 | 2.0 |
Blood Donors | 2 | 0.0 |
Complement 6/metabolism | 2 | 20.0 |
*Evolution | 2 | 1.0 |
*Complement 9/genetics | 2 | 100.0 |
Complement Factor H | 3 | 3.0 |
Thrombin/metabolism | 2 | 1.0 |
Macrophages/*immunology | 2 | 0.0 |
Monocytes/*immunology | 2 | 0.0 |
Antigen-Antibody Complex | 9 | 5.0 |
Cell Membrane Permeability | 2 | 1.0 |
Erythrocyte Membrane/metabolism | 4 | 6.0 |
Linoleic Acids/*pharmacology | 4 | 36.0 |
Glomerulonephritis, IGA/*immunology | 2 | 11.0 |
Antibodies | 5 | 1.0 |
Cell Membrane/ultrastructure | 2 | 4.0 |
Fibronectins/analysis | 2 | 3.0 |
*Cloning, Molecular | 4 | 1.0 |
Biotransformation | 2 | 0.0 |
Fatty Acids/*analysis | 2 | 11.0 |
Complement 9/*immunology/isolation & purification | 2 | 100.0 |
*Lymphotoxin | 2 | 100.0 |
Proteins/*immunology/isolation & purification | 2 | 100.0 |
Cell Membrane/immunology | 3 | 1.0 |
Complement/analysis/*immunology | 2 | 40.0 |
Hemolytic Plaque Technique | 2 | 3.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Immunoglobulins/*analysis | 7 | 7.0 |
Arthritis, Rheumatoid/immunology | 3 | 3.0 |
Behcet Syndrome/*immunology | 2 | 9.0 |
Lupus Erythematosus, Systemic/immunology | 2 | 1.0 |
Radioimmunoassay | 2 | 0.0 |
Erythrocytes/*immunology | 9 | 4.0 |
Hemoglobinuria, Paroxysmal/*immunology | 3 | 13.0 |
Complement | 3 | 6.0 |
Membrane Potentials | 2 | 0.0 |
Peptide Fragments/immunology | 2 | 0.0 |
Complement 9/*physiology | 3 | 100.0 |
Immunoelectrophoresis | 2 | 0.0 |
Complement 9/*analysis/immunology | 2 | 100.0 |
*Liposomes | 2 | 5.0 |
Carbohydrates/analysis | 2 | 3.0 |
Complement 8/isolation & purification/*metabolism | 2 | 100.0 |
Edetic Acid | 2 | 4.0 |
Complement 5 | 4 | 36.0 |
Complement 6 | 2 | 50.0 |
Complement 7/isolation & purification | 2 | 100.0 |
Complement 2/genetics | 2 | 4.0 |
Complement 4/genetics | 2 | 3.0 |
Complement Factor B/genetics | 2 | 2.0 |
Peptide Hydrolases/pharmacology | 3 | 18.0 |
Arteriosclerosis/*immunology | 2 | 13.0 |
Fibrinogen/analysis | 3 | 1.0 |
Immunoelectrophoresis, Two-Dimensional | 4 | 3.0 |
Serum Albumin/analysis | 2 | 1.0 |
Transferrin/analysis | 2 | 2.0 |
alpha 1-Antitrypsin/analysis | 3 | 3.0 |
*Smoking | 2 | 2.0 |
Immunoglobulin G | 5 | 4.0 |
Goats/immunology | 3 | 14.0 |
Receptors, Complement/analysis | 2 | 3.0 |
Complement 3 Convertase | 2 | 22.0 |
Densitometry | 2 | 1.0 |
Cations, Divalent | 2 | 2.0 |
Trypsin | 2 | 1.0 |
Columbidae | 2 | 13.0 |
Erythrocytes/*metabolism | 2 | 0.0 |
*Dinitrophenols | 2 | 100.0 |
*Immunochemistry | 2 | 66.0 |
Inulin/pharmacology | 2 | 40.0 |
Zymosan/pharmacology | 3 | 3.0 |
Complement Activating Enzymes/deficiency | 2 | 33.0 |
Protein-Energy Malnutrition/*immunology | 2 | 66.0 |
Antibodies, Bacterial/immunology | 2 | 4.0 |
Antibody Formation | 2 | 0.0 |
Antigen-Antibody Complex/analysis | 2 | 1.0 |
Autoantibodies/analysis | 3 | 1.0 |
Rats, Inbred Strains | 2 | 0.0 |
Chemistry | 3 | 1.0 |
*Luminescent Measurements | 2 | 10.0 |
Azides | 2 | 18.0 |
Vaccination | 2 | 1.0 |
Complement 6/analysis | 2 | 15.0 |
Postpartum Period | 2 | 2.0 |
Pre-Eclampsia/*immunology | 2 | 14.0 |
*Pregnancy | 2 | 1.0 |
Orosomucoid/analysis | 2 | 4.0 |
Alopecia Areata/*immunology | 2 | 33.0 |
Complement 3 | 2 | 5.0 |
Complement 9 | 4 | 57.0 |
*Complement | 6 | 9.0 |
Radioisotopes | 2 | 15.0 |
Rubidium | 2 | 66.0 |
Polyethylene Glycols/pharmacology | 3 | 6.0 |
Immunity, Cellular | 2 | 0.0 |
*Infant, Newborn | 2 | 4.0 |
Immunoglobulin A | 2 | 22.0 |
*Complement/analysis | 3 | 37.0 |
Histamine Release | 2 | 3.0 |
Macaca | 2 | 2.0 |
Rabbits/immunology | 3 | 3.0 |
Guinea Pigs/immunology | 2 | 13.0 |
Sheep/immunology | 2 | 8.0 |
